Euroapi H1 net loss widens to EUR 141.5 million; revenue falls 13.5% to EUR 356.5 million vs H1 FY25

• Euroapi posted H1 2026 sales of EUR 356.5 million, down 13.5% year on year; net loss widened to EUR 141.5 million.
• Core EBITDA fell to EUR 20.7 million, cutting the margin to 5.8%; EBITDA turned to a loss of EUR 43.1 million.
• Net debt was EUR 37.9 million at end-June; the group cited EUR 42.5 million in exceptional personnel charges tied to FOCUS-27.
• Signed an agreement to sell the Brindisi site subsidiary to Huvepharma for EUR 5 million enterprise value, with EUR 60 million transition support over two years.
• Euroapi kept its 2026 sales view, while guiding Core EBITDA margin around 6% on a roughly EUR 9 million forint headwind.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Euroapi SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607291143OMX_____CNEWS_FR_GNW1001255046_fr) on July 29, 2026, and is solely responsible for the information contained therein.